Ensign Group

Valuation Analysis

About the Company

Ensign Group en bref

Ensign Group (ENSG) is currently trading at 134,09 € with a market capitalization of 7,8 Md €. The trailing P/E ratio stands at 25.02x, with a forward P/E of 18.45x. The 52-week range spans from 117,63 € to 190,24 €; the current price is 29.5% below the yearly high. Year-over-year revenue growth stands at +18.4%. The net profit margin stands at 6.89%.

💰 Dividende

Ensign Group currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

5 analystes évaluent Ensign Group (ENSG) au consensus : Acheter. L'objectif de cours moyen est de 192,34 €, soit un potentiel de +43.44% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 183,26 € à 200,72 €.

Ensign Group : la thèse d'investissement en détail

Ensign Group (ENSG) operates in the Healthcare — specifically Medical Care Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 18.4% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Wall Street consensus sits at Buy with an average price target implying roughly 43.44% upside from current levels — analyst sentiment is firmly constructive.

Valorisation en contexte

The PEG ratio at 1.38 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

À surveiller

• The forward P/E of 18.45x is meaningfully below the trailing 25.02x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 43.44% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

Related Stocks in the Same Sector

Where can I buy Ensign Group?

Compare top-rated brokers — low fees, trusted providers, fully regulated.